NEWS

Oost NL conducts a €2.6 million financing round for a company that fights severe knee osteoarthritis

01/20/2023

Today we want to share with you a case of how regional development agencies interact with relevant social agents such as health companies to create wellness in society and face some current problems.

ArthroSave has developed a unique joint-saving treatment for patients with severe knee osteoarthritis. A new investment round of € 2.6 million, led by Oost NL, enables ArthroSave to perform clinical trials and accelerate the commercialisation of the KneeReviver.

Patients with knee osteoarthritis have a damaged knee joint and suffer from persistent pain every day. In Europe alone, over 2.2 million patients are affected by knee osteoarthritis which is increasing dramatically, due to rising obesity rates and the ageing population. The only effective treatment so far is artificial knee joint replacement. However, artificial joints have a limited life span and fail over time, requiring revision surgery associated with higher mortality, inferior outcomes and higher costs. With more young people presenting with knee osteoarthritis and increasing life expectancy, there is an unmet need to postpone the time to first knee replacement.

Karianne Lindenhovius, CEO and co-founder of ArthroSave, explains: “ArthroSave has developed the KneeReviver enabling knee joint distraction as a joint preserving solution. Knee joint distraction with the KneeReviver is a temporary treatment that unloads the knee joint for six weeks. This results in the relief of pain and improvement of function. Due to the regeneration of the joint, the original knee joint will be preserved. This will postpone the knee placement surgery for 10 more years and will prevent complex revision surgery later in life.”

Thomas Hensel, Investment manager Health at Oost NL: “ArthroSave's solution gives patients with knee osteoarthritis more quality of life. In addition, it is a solution that helps reduce healthcare costs, as potentially fewer artificial knee repair surgeries are needed. That combination makes ArthroSave a valuable company that has developed positively in recent years. Reason for us to invest again in Karianne and her team.” Oost NL invests from ‘Innovatie- en Energiefonds Gelderland’, an innovation fund from the province of Gelderland that Oost NL manages.